C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 239/72 (2006.01) A01N 43/54 (2006.01) C07D 401/00 (2006.01) C07D 487/04 (2006.01)
Patent
CA 2291709
The present invention relates to compounds which inhibit tyrosine kinase enzymes, compositions which contain tyrosine kinase inhibiting compounds and methods of using tyrosine kinase inhibitors to treat tyrosine kinase-dependent diseases/conditions such as angiogenesis, cancer, atherosclerosis, diabetic retinopathy or autoimmune diseases, in mammals.
La présente invention concerne des composés qui inhibent des enzymes de type tyrosine kinase, des compositions qui contiennent ces composés inhibant la tyrosine kinase, et des procédés d'utilisation des inhibiteurs de tyrosine kinase permettant de traiter des états/maladies dépendant de la tyrosine kinase tels que l'angiogénèse, le cancer, l'athérosclérose, la rétinopathie diabétique ou des maladies auto-immunes chez les mammifères.
Bilodeau Mark T.
Fraley Mark E.
Hungate Randall W.
Kendall Richard L.
Rubino Robert
Merck & Co. Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Novel angiogenesis inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel angiogenesis inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel angiogenesis inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1767373